ADVANCED ENDOMETRIAL CANCER
Clinical trials for ADVANCED ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to control advanced uterine cancer
Disease control Not yet recruitingThis study tests whether adding an experimental drug called EG-007 to a standard two-drug combination (lenvatinib and pembrolizumab) is safe and tolerable for people with advanced or recurrent endometrial cancer. About 28 adults whose cancer has returned after chemotherapy will t…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New hope for advanced endometrial cancer: triple therapy trial launches
Disease control Not yet recruitingThis phase 3 trial tests whether adding the drug EG007 to the standard combination of lenvatinib and pembrolizumab can better control advanced endometrial cancer. About 450 women whose cancer has returned or spread despite prior chemotherapy will be randomly assigned to receive e…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE3 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC